Novel Approaches in Advancing the Treatment of Epithelial Ovarian Cancer: The Role of Angiogenesis Inhibition
- 10 July 2007
- journal article
- review article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 25 (20), 2894-2901
- https://doi.org/10.1200/jco.2007.11.1088
Abstract
Despite an aggressive approach of surgical cytoreduction and adjuvant combination chemotherapy, ovarian cancer mortality remains a significant problem. We are entering a new era of cancer therapeutics in which targeted therapies offer the potential for improvement in long-term disease control with fewer toxicities. The greatest success of targeted therapy to date in the setting of epithelial ovarian carcinoma has come from angiogenesis inhibition. This review will focus on the role of angiogenesis in normal ovarian function as well as in ovarian carcinoma development and disease progression. Current knowledge about the molecular pathways involved in angiogenesis and various approaches to angiogenesis inhibition in the treatment of ovarian cancer are discussed. Current data regarding the role of bevacizumab and other novel agents in the treatment of ovarian carcinoma are summarized.Keywords
This publication has 72 references indexed in Scilit:
- Relevant molecular markers and targetsGynecologic Oncology, 2006
- Novel therapeutic agents in ovarian cancerEuropean Journal of Surgical Oncology, 2006
- CCI-779 Inhibits Rhabdomyosarcoma Xenograft Growth by an Antiangiogenic Mechanism Linked to the Targeting of mTOR/Hif-1α/VEGF SignalingNeoplasia, 2006
- Angiogenesis in normal and neoplastic ovariesAngiogenesis, 2005
- Pancreatic carcinoma cells express neuropilins and vascular endothelial growth factor, but not vascular endothelial growth factor receptorsCancer, 2004
- G1cell cycle progression and the expression of G1cyclins are regulated by PI3K/AKT/mTOR/p70S6K1 signaling in human ovarian cancer cellsAmerican Journal of Physiology-Cell Physiology, 2004
- Expression of the angopoietin-1, angopoietin-2, Tie2, and vascular endothelial growth factor gene in epithelial ovarian cancerGynecologic Oncology, 2004
- The biology of VEGF and its receptorsNature Medicine, 2003
- Vascular Channel Formation by Human Melanoma Cells in Vivo and in Vitro: Vasculogenic MimicryThe American Journal of Pathology, 1999
- Characteristics of EGFR family-mediated HRG signals in human ovarian cancerJournal of Cellular Biochemistry, 1999